ReviewTherapeutic advances in gastroenterology2018

Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.

Kentaro SuganoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.